Total, n=5379 | |||||||
hsCRP (mg/L) | D-dimer (μg/mL) | Fibrinogen (mg/dL) | Homocysteine (μmol/L) | hs-cTnT (ng/L) | NT-ProBNP (pg/mL) | IL-6* (pg/mL) | |
Model 1 | −0.16
(−0.17, −0.14) | −0.06
(−0.07, −0.05) | −0.02
(−0.03, −0.02) | −0.02
(−0.02, −0.01) | −0.05
(−0.06, −0.05) | 0.00004 (−0.01, 0.01) | −0.09
(−0.10, −0.08) |
Model 2 | −0.13
(−0.14, − 0.12) | −0.03
(−0.04, −0.02) | −0.02
(−0.02, −0.02) | −0.01
(−0.01, −0.01) | −0.04
(−0.05, −0.03) |
0.02
(0.01, 0.03) | −0.07
(−0.08, −0.06) |
Women, n=2775 | |||||||
Model 1 | −0.18
(−0.20, −0.16) | −0.07
(−0.09, −0.06) | −0.03
(−0.03, −0.03) | −0.02
(−0.03, −0.02) | −0.04
(−0.05, − 0.04) | 0.01 (−0.01,0.03) | −0.11
(−0.12, −0.10) |
Model 2 | −0.16
(−0.18, −0.14) | −0.03
(−0.05, −0.02) | −0.02
(−0.03, −0.02) | −0.01
(−0.02, −0.01) | −0.03
(−0.04, −0.02) |
0.03
(0.01, 0.04) | −0.08
(−0.09, −0.07) |
Men, n=2604 | |||||||
Model 1 | −0.13
(−0.15, −0.11) | −0.04
(−0.05, −0.02) | −0.02
(−0.02, −0.02) | −0.01
(−0.02, −0.01) | −0.07
(−0.08, −0.06) | −0.01 (−0.03, 0.01) | −0.07
(−0.08, −0.06) |
Model 2 | −0.10
(−0.12, −0.08) | −0.02
(−0.03, −0.001) | −0.02
(−0.02, −0.01) | −0.01
(−0.01, −0.004) | −0.06
(−0.07, −0.05) | 0.005 (−0.01, 0.02) | −0.05
(−0.06, −0.04) |
*For IL-6, total sample size = 5279; women, n = 2733; men, n = 2546.
CVD, cardiovascular disease;CVH, cardiovascular health; hsCRP, high-sensitivity C-reactive protein; hs-cTnT, high-sensitivity cardiac troponin T; IL-6, interleukin 6; NT-proBNP, N-terminal pro B-type natriuretic peptide.